Both in Pharmaceuticals

Zai Lab Limited vs Structure Therapeutics

Over the past year ZLAB returned −21.3% and GPCR returned +29.2%; their daily moves had a correlation of 0.09.

ZLAB −21.3% GPCR +29.2%Growth of $1, one year, split-adjusted
MetricZLABGPCR
Price$25.93$32.69
Market cap$2.91B$2.33B
Today+0.93%−6.77%
1 month−0.6%−31.0%
6 months+45.3%−25.6%
Year to date+47.0%−53.0%
1 year−18.0%+30.8%
Revenue growth (YoY)−3.3%—
Gross margin54.7%—
Net margin−47.8%—
P/E (TTM)——
Price / sales6.5×—
Net cash$379.4M$1.34B
Dividend yield——
Volatility (60d)53.2%57.3%
Short % of float——
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

ZLAB vs GPCR: Zai Lab Limited vs Structure Therapeutics Stock Comparison | Gainbot